Crossmark

Differentiation of malignant from benign soft tissue tumors using radiomics based on pharmacokinetic parameter maps obtained from dynamic contrast-enhanced magnetic resonance imaging data

Crossref DOI link: https://doi.org/10.1007/s42058-024-00154-z

Published Online: 2024-06-18

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hao, Jingwei https://orcid.org/0009-0009-9505-6878
Liu, Shunli

Wang, Tongyu

Han, Xiaomeng

Gao, Aixin

Wang, Hexiang

Hao, Dapeng
Funding

Funding for this research was provided by:

Natural Science Foundation of Shandong Province (ZR2020MH286, ZR2021MH159)

National Natural Science Foundation of China (82172035)
License Information

Text and Data Mining valid from 2024-06-18

Version of Record valid from 2024-06-18
More Information

Article History

Received: 27 November 2023

Revised: 27 February 2024

Accepted: 14 May 2024

First Online: 18 June 2024

Declarations

:

: All authors disclosed no relevant relationships. This research did not involve Human Participants and Animals. This retrospective study received ethical approval from the hospital’s institutional review board, and the requirement for written informed consent was waived.

: All authors disclosed no relevant relationships.

Document is current

Any future updates will be listed below